- Home
- TRT
as 07-26-2024 4:00pm EST
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China.
| Founded: | 1958 | Country: | United States |
| Employees: | N/A | City: | VAN NUYS |
| Market Cap: | 25.0M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 3.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.23 | EPS Growth: | -55.77 |
| 52 Week Low/High: | $4.64 - $8.62 | Next Earning Date: | 05-13-2024 |
| Revenue: | $41,645,000 | Revenue Growth: | -9.48% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Trio-Tech International News
TRT Breaking Stock News: Dive into TRT Ticker-Specific Updates for Smart Investing
Business Wire
2 months ago
Trio-Tech Reports Improved Third Quarter Results
Business Wire
5 months ago
Trio-Tech Reports Second Quarter Results
GlobeNewswire
6 months ago
PodcastOne Renews Agreement with The Adam Carolla Podcast and The Adam and Dr. Drew Show
Simply Wall St.
6 months ago
We Think Allied Gaming & Entertainment (NASDAQ:AGAE) Can Afford To Drive Business Growth
Simply Wall St.
6 months ago
Spero Therapeutics, Inc. (NASDAQ:SPRO): Are Analysts Optimistic?
GlobeNewswire
6 months ago
NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders
Business Wire
6 months ago
Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay
GlobeNewswire
7 months ago
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenue
Compare TRT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TRT Trio-Tech International - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.